Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000286198 | SCV000445940 | benign | Tietz syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000343441 | SCV000445941 | benign | Waardenburg syndrome type 2A | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589785 | SCV000696086 | benign | not provided | 2016-03-09 | criteria provided, single submitter | clinical testing | Variant summary: This c.1248G>A variant affects a non-conserved nucleotide, resulting in synonymous amino acid change. 5/5 splice-site tools via Alamut predict that this variant does not affect normal splicing. This variant was found in 492/120528 control chromosomes from the broad and large populations of ExAC at a frequency of 0.004082, predominantly in South Asian population with an allele frequency of 0.02967 (488/16448 chromosomes) including 12 homozygous occurrences. These frequencies are significantly greater than the maximal expected frequency of a pathogenic allele (0.0000125) in this gene, suggesting this variant is a benign polymorphism mainly found in South Asian population. The variant has not been reported in individuals with phenotypes linked to this gene, to our knowledge. Taken together, this variant has been classified as Benign. |
Invitae | RCV002520184 | SCV001034667 | benign | Tietz syndrome; Waardenburg syndrome type 2A; Melanoma, cutaneous malignant, susceptibility to, 8 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589785 | SCV001771613 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001580039 | SCV002550870 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316496 | SCV004015855 | likely benign | Melanoma, cutaneous malignant, susceptibility to, 8 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001580039 | SCV001809450 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001580039 | SCV001921756 | benign | not specified | no assertion criteria provided | clinical testing |